The Dividend Yield as of September 2024 (TTM) for Larimar Therapeutics, Inc. (LRMR) is 0%

According to Larimar Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Larimar Therapeutics, Inc. (LRMR) Historical Dividend Yield (quarterly & annually)

How has LRMR Dividend Yield performed in the past?

The mean historical Dividend Yield of Larimar Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), LRMR's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Larimar Therapeutics, Inc. (LRMR) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Larimar Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Larimar Therapeutics, Inc. (LRMR) Average Dividend Yield

How has LRMR Dividend Yield performed in the past?

The current Dividend Yield of Larimar Therapeutics, Inc. (LRMR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Larimar Therapeutics, Inc. (LRMR) Dividend Yield vs. Peers

How is LRMR’s Dividend Yield compared to its peers?

Larimar Therapeutics, Inc.’s Dividend Yield is less than Vaxcyte, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Merus N.V. (0%), less than Sutro Biopharma, Inc. (0%), less than Immuneering Corporation (0%), less than Centessa Pharmaceuticals plc (0%), less than Celcuity Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Coherus BioSciences, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Surrozen, Inc. (0%), less than Keros Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than Cabaletta Bio, Inc. (0%), less than Homology Medicines, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Alector, Inc. (0%),

Build a custom stock screener for Larimar Therapeutics, Inc. (LRMR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Larimar Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Larimar Therapeutics, Inc. (LRMR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Larimar Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.